SE461570B - Farmaceutiskt preparat och konjugat av en baktericid och en antikropp - Google Patents

Farmaceutiskt preparat och konjugat av en baktericid och en antikropp

Info

Publication number
SE461570B
SE461570B SE8802084A SE8802084A SE461570B SE 461570 B SE461570 B SE 461570B SE 8802084 A SE8802084 A SE 8802084A SE 8802084 A SE8802084 A SE 8802084A SE 461570 B SE461570 B SE 461570B
Authority
SE
Sweden
Prior art keywords
antibody
conjugate
bactericide
directed against
netilmicin
Prior art date
Application number
SE8802084A
Other languages
English (en)
Swedish (sv)
Other versions
SE8802084L (sv
SE8802084D0 (sv
Inventor
G Fredriksson
M Bergryd
Original Assignee
Rama Bio Link Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rama Bio Link Ab filed Critical Rama Bio Link Ab
Priority to SE8802084A priority Critical patent/SE461570B/sv
Publication of SE8802084D0 publication Critical patent/SE8802084D0/xx
Priority to EP89906837A priority patent/EP0419532A1/en
Priority to PCT/SE1989/000311 priority patent/WO1989011866A1/en
Priority to AU37635/89A priority patent/AU3763589A/en
Publication of SE8802084L publication Critical patent/SE8802084L/xx
Publication of SE461570B publication Critical patent/SE461570B/sv
Priority to DK289090A priority patent/DK161892C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/44—Antibodies bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6807—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug or compound being a sugar, nucleoside, nucleotide, nucleic acid, e.g. RNA antisense
    • A61K47/6809—Antibiotics, e.g. antitumor antibiotics anthracyclins, adriamycin, doxorubicin or daunomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Birds (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8802084A 1988-06-06 1988-06-06 Farmaceutiskt preparat och konjugat av en baktericid och en antikropp SE461570B (sv)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE8802084A SE461570B (sv) 1988-06-06 1988-06-06 Farmaceutiskt preparat och konjugat av en baktericid och en antikropp
EP89906837A EP0419532A1 (en) 1988-06-06 1989-06-02 A pharmaceutical preparation and a conjugate of a bactericide and an antibody directed against plaque forming or caries-inducing bacteria
PCT/SE1989/000311 WO1989011866A1 (en) 1988-06-06 1989-06-02 A pharmaceutical preparation and a conjugate of a bactericide and an antibody directed against plaque forming or caries-inducing bacteria
AU37635/89A AU3763589A (en) 1988-06-06 1989-06-02 A pharmaceutical preparation and a conjugate of a bactericide and an antibody directed against plaque forming or caries-inducing bacteria
DK289090A DK161892C (da) 1988-06-06 1990-12-05 Farmaceutisk praeparat samt konjugat af et baktericid og et antistof rettet mod plaque-dannende eller caries-inducerende bakterier

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8802084A SE461570B (sv) 1988-06-06 1988-06-06 Farmaceutiskt preparat och konjugat av en baktericid och en antikropp

Publications (3)

Publication Number Publication Date
SE8802084D0 SE8802084D0 (sv) 1988-06-06
SE8802084L SE8802084L (sv) 1989-12-07
SE461570B true SE461570B (sv) 1990-03-05

Family

ID=20372517

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8802084A SE461570B (sv) 1988-06-06 1988-06-06 Farmaceutiskt preparat och konjugat av en baktericid och en antikropp

Country Status (5)

Country Link
EP (1) EP0419532A1 (da)
AU (1) AU3763589A (da)
DK (1) DK161892C (da)
SE (1) SE461570B (da)
WO (1) WO1989011866A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9021671D0 (en) * 1990-10-05 1990-11-21 Unilever Plc Delivery of agents
AU642979B2 (en) * 1990-03-21 1993-11-04 Quest International B.V. Utilization and delivery of enzymes
AU641736B2 (en) * 1990-03-21 1993-09-30 Quest International B.V. Delivery of agents
CN101002947B (zh) * 2007-01-16 2010-08-25 湖南农业大学 一种用于细菌病治疗的靶向药物及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1433593A (en) * 1972-06-09 1976-04-28 Royal College Of Surgeons Conjugates
US4671958A (en) * 1982-03-09 1987-06-09 Cytogen Corporation Antibody conjugates for the delivery of compounds to target sites
US4699784A (en) * 1986-02-25 1987-10-13 Center For Molecular Medicine & Immunology Tumoricidal methotrexate-antibody conjugate

Also Published As

Publication number Publication date
SE8802084L (sv) 1989-12-07
SE8802084D0 (sv) 1988-06-06
DK289090D0 (da) 1990-12-05
DK161892B (da) 1991-08-26
AU3763589A (en) 1990-01-05
WO1989011866A1 (en) 1989-12-14
EP0419532A1 (en) 1991-04-03
DK289090A (da) 1990-12-05
DK161892C (da) 1992-03-09

Similar Documents

Publication Publication Date Title
CA2066777C (en) Monoclonal antibody to enterohemorrhagic escherichia coli 0157:h7 and 026:h11 and method for detection
DE3486146T2 (de) Monoklonale antikörper gegen endotoxine von gramnegativen bakterien.
Eichel-Streiber et al. Purification of two high molecular weight toxins of Clostridium difficile which are antigenically related
DE3751467T2 (de) Plasmid zur Herstellung von Membranprotein, dieses Plasmid enthaltendes Bakterium, monoklonaler Antikörper hierfür und Verfahren zur Identifikation von Hämophilus influenzae.
KR0158436B1 (ko) 개선된 수막염균성 폴리사카라이드 결합체 백신
JP2645665B2 (ja) ヒトモノクローナル抗体
Tadjine et al. Production and characterization of murine monoclonal antibodies against Haemophilus parasuis and study of their protective role in mice
JP2805490B2 (ja) 細菌毒素中和剤
SE461570B (sv) Farmaceutiskt preparat och konjugat av en baktericid och en antikropp
Mekalanos et al. Affinity filters, a new approach to the isolation of tox mutants of Vibrio cholerae.
DK398683D0 (da) Fremgangsmade til fremstilling af antistoffer
DiRienzo et al. Monoclonal antibodies to leukotoxin of Actinobacillus actinomycetemcomitans
Nakasone et al. Pili of Vibrio cholerae non-O1
Ogunnariwo et al. Evidence for non-siderophore-mediated acquisition of transferrin-bound iron by Pasteurella multocida
Gustafsson et al. Immunological characterization of Vibrio cholerae O: 1 lipopolysaccharide, O-side chain, and core with monoclonal antibodies
Marandi et al. Characterization of an outer membrane protein of Pasteurella multocida belonging to the OmpA family
JP2691708B2 (ja) ヒトモノクローナル抗体およびその製法
DE69910409T2 (de) Disaccharide-derivate
Bundesen et al. Monoclonal antibodies directed against Brucella abortus cell surface antigens
Bailey et al. Evidence for the presence of lipopolysaccharide in Treponema phagedenis (biotype Reiterii) but not in Treponema pallidum (Nichols)
DE3722098A1 (de) Monoklonale antikoerper gegen pseudomonas aeruginosa flagella
Hamada et al. Characterization of a monoclonal antibody specific for lipoteichoic acid from various Gram‐positive bacteria
Stinson et al. Binding of Streptococcus mutans antigens to heart and kidney basement membranes
Tagawa et al. Antigenic analysis of the major outer membrane protein of Haemophilus somnus with monoclonal antibodies
GB2214509A (en) Human monoclonal antibody and its production and use.

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8802084-7

Effective date: 19950110

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8802084-7

Format of ref document f/p: F